| Title |
Longitudinal Evaluation of Neuromuscular Dysfunction in Long-term Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study
|
|---|---|
| Published in |
Cancer Epidemiology, Biomarkers & Prevention, June 2021
|
| DOI | 10.1158/1055-9965.epi-21-0154 |
| Pubmed ID | |
| Authors |
Rozalyn L Rodwin, Yan Chen, Yutaka Yasui, Wendy M Leisenring, Todd M Gibson, Paul C Nathan, Rebecca M Howell, Kevin R Krull, Caroline Mohrmann, Robert J Hayashi, Eric J Chow, Kevin C Oeffinger, Gregory T Armstrong, Kirsten K Ness, Nina S Kadan-Lottick |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 33% |
| Canada | 1 | 17% |
| Unknown | 3 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 67% |
| Practitioners (doctors, other healthcare professionals) | 2 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 21 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 3 | 14% |
| Student > Master | 2 | 10% |
| Student > Postgraduate | 2 | 10% |
| Researcher | 1 | 5% |
| Librarian | 1 | 5% |
| Other | 0 | 0% |
| Unknown | 12 | 57% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 3 | 14% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 5% |
| Biochemistry, Genetics and Molecular Biology | 1 | 5% |
| Psychology | 1 | 5% |
| Nursing and Health Professions | 1 | 5% |
| Other | 2 | 10% |
| Unknown | 12 | 57% |
Attention Score in Context
This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 August 2021.
All research outputs
#2,855,207
of 25,477,125 outputs
Outputs from Cancer Epidemiology, Biomarkers & Prevention
#837
of 4,852 outputs
Outputs of similar age
#70,227
of 458,981 outputs
Outputs of similar age from Cancer Epidemiology, Biomarkers & Prevention
#17
of 62 outputs
Altmetric has tracked 25,477,125 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,852 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 16.5. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 458,981 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 62 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.